2 reports of this reaction
1.7% of all CARBAMIDE PEROXIDE 6.5% reports
#11 most reported adverse reaction
NERVE COMPRESSION is the #11 most commonly reported adverse reaction for CARBAMIDE PEROXIDE 6.5%, manufactured by Bionpharma Inc.. There are 2 FDA adverse event reports linking CARBAMIDE PEROXIDE 6.5% to NERVE COMPRESSION. This represents approximately 1.7% of all 120 adverse event reports for this drug.
Patients taking CARBAMIDE PEROXIDE 6.5% who experience nerve compression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NERVE COMPRESSION is a less commonly reported adverse event for CARBAMIDE PEROXIDE 6.5%, but still significant enough to appear in the safety profile.
In addition to nerve compression, the following adverse reactions have been reported for CARBAMIDE PEROXIDE 6.5%:
NERVE COMPRESSION has been reported as an adverse event in 2 FDA reports for CARBAMIDE PEROXIDE 6.5%. This does not prove causation, but indicates an association observed in post-market surveillance data.
NERVE COMPRESSION accounts for approximately 1.7% of all adverse event reports for CARBAMIDE PEROXIDE 6.5%, making it a notable side effect.
If you experience nerve compression while taking CARBAMIDE PEROXIDE 6.5%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.